| Targeting tumor mitochondrial metabolism overcomes resistance to antiangiogenics P Navarro, MJ Bueno, I Zagorac, T Mondejar, J Sanchez, S Mourón, ... Cell reports 15 (12), 2705-2718, 2016 | 101 | 2016 |
| In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer I Zagorac, S Fernandez-Gaitero, R Penning, H Post, MJ Bueno, S Mouron, ... Nature communications 9 (1), 3501, 2018 | 54 | 2018 |
| Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia J Martínez-López, M Linares, ML Morales, A Arenas, I Zagorac, RM Ayala, ... Blood 128 (22), 1581-1581, 2016 | 1 | 2016 |
| PHOSPHOPROTEOMIC CHARACTERIZATION OF THE RESISTANCE IN LMA: MEK AS A NEW DIANA TO ENHANCE THE RESPONSE TO ITKS ML Morales, A Arenas, A Ortiz-Ruiz, A Leivas, I Rapado, ... HAEMATOLOGICA 103, 24-25, 2018 | | 2018 |
| TRAMETINIB PROMOTES RESPONSE TO TYROSINE KINASE INHIBITORS IN ACUTE MYELOID LEUKEMIA ML Morales, M Linares, A Arenas, A Leivas, I Zagorac, R Ayala, N Castro, ... HAEMATOLOGICA 102, 79-80, 2017 | | 2017 |
| Triple-negative breast cancer (TNBC) phosphoproteomics SF Gaitero, I Zagorac, JF Lopez-Acosta, G Gomez-Lopez, DG Pisano, ... Cancer Research 77 (13 Supplement), 1221-1221, 2017 | | 2017 |
| PRECLINICAL EVIDENCE THAT TRAMETINIB ENHANCES THE RESPONSE TO TYROSINE KINASE INHIBITORS IN ACUTE MYELOID LEUKEMIA ML Morales, M Linares, A Arenas, I Zagorac, R Ayala, N Castro, I Rapado, ... HAEMATOLOGICA 102, 369-369, 2017 | | 2017 |
| Phosphoproteomic portraits of triple-negative breast cancer (TNBC). M Quintela-Fandino, I Zagorac, JF Lopez-Acosta, G Gomez, DG Pisano, ... Journal of Clinical Oncology 34 (15_suppl), 1071-1071, 2016 | | 2016 |
| Abstract B9: A phosphoproteomic portrait of triple-negative breast cancer: functional taxonomy I Zagorac, TM Tevar, JS Ruíz, A Heck, M Altelaar, R Penning, H Post, ... Molecular Cancer Therapeutics 14 (12 Supplement 2), B9-B9, 2015 | | 2015 |
